Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Annamycin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Moleculin Announces New Annamycin Collaboration in Brain Tumors
    Moleculin Announces New Annamycin Collaboration in Brain Tumors

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201521/0/en/Moleculin-Announces-New-Annamycin-Collaboration-in-Brain-Tumors.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Moleculin Reaches 60% Consent in MIRACLE AML Trial
    Moleculin Reaches 60% Consent in MIRACLE AML Trial

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187380/0/en/Moleculin-Reports-60-of-First-45-Subjects-in-Pivotal-MIRACLE-Phase-3-AML-Trial-Consented.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Moleculin Announces Grant Funded Research Evaluating Annamycin
    Moleculin Announces Grant Funded Research Evaluating Annamycin

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186289/0/en/Moleculin-Announces-Grant-Funded-Research-Evaluating-Annamycin-for-the-Treatment-of-Pancreatic-Cancer-at-UNC-Chapel-Hill.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Moleculin Highlights Ph 3 AML MIRACLE Trial at Leukemia Meet
    Moleculin Highlights Ph 3 AML MIRACLE Trial at Leukemia Meet

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177430/0/en/Moleculin-to-Highlight-its-Ongoing-Phase-3-Acute-Myeloid-Leukemia-MIRACLE-Clinical-Trial-at-the-14th-Annual-Acute-Leukemia-Meeting.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Moleculin Expands Global IP With Australian Patent For Annamycin
    Moleculin Expands Global IP With Australian Patent For Annamycin

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176459/0/en/Moleculin-Expands-Global-IP-Portfolio-with-New-Australian-Patent-for-Annamycin.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Moleculin Initiates Study On Annamycin For Pancreatic Cancer
    Moleculin Initiates Study On Annamycin For Pancreatic Cancer

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171983/0/en/Moleculin-Announces-New-Investigator-Initiated-Study-of-Annamycin-for-Treating-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.